Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Kidney and Urinary TractDRG 654-major-bladder-procedures-with-cc
    Ask Trek AI about this page

    Major Bladder Procedures with CC: Inpatient Reimbursement Overview

    DRG 654 encompasses major bladder procedures performed with a Complication or Comorbidity and defines the inpatient clinical scope for complex bladder surgery billing. Correct assignment affects Medicare inpatient reimbursement by reflecting higher resource intensity when complications or comorbid conditions are present.

    Customize your policy alerts

    Sign up for drg 654 policy alerts

    Get alerted when payer policies referencing 654 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 654 Overview

    DRG 654 covers hospital admissions for major bladder procedures when a Complication or Comorbidity is present, including cystectomy with complex reconstruction or extensive bladder surgery. This Diagnosis-Related Group groups clinically similar cases with comparable resource use for Medicare payment. It matters because the presence of a Complication or Comorbidity increases expected resource consumption and influences inpatient reimbursement under Medicare. Hospitals and coders must correctly identify procedures and associated diagnoses to ensure accurate assignment to this Diagnosis-Related Group.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative optimization and enhanced recovery protocols for patients undergoing major bladder procedures with CC: randomized or pragmatic studies comparing different preoperative and intraoperative care bundles (eg, fluid management, analgesia pathways, and infection prevention strategies) in adults undergoing open or minimally invasive cystectomy or other major bladder surgeries complicated by comorbid conditions. These trials enroll patients with significant comorbidities (eg, cardiac, pulmonary, renal dysfunction, or active infection) who drive the CC classification and examine short-term perioperative morbidity, length of stay, and readmission. Results are highly relevant to providers and payers because reducing complications and LOS directly affects inpatient resource use, costs, and readmission penalties.
    • Comparative effectiveness research on surgical approaches and reconstruction techniques in complex bladder procedures: multicenter observational cohorts or randomized trials comparing open versus robotic-assisted approaches, different urinary diversion types, or reconstruction timing in patients with high comorbidity burden or prior pelvic surgery/radiation. These studies focus on intermediate outcomes such as complication rates, need for reoperation, functional outcomes (eg, continence), and resource utilization in the higher-risk population captured by this DRG. Payers and health systems use this evidence to inform coverage decisions, network referral patterns, and bundled payment designs aimed at optimizing value for complex surgical patients.
    • Post-discharge outcomes and long-term survivorship studies evaluating readmissions, complication trajectories, and patient-reported outcomes after major bladder procedures: prospective registries or longitudinal cohort studies tracking patients from hospital discharge through 6–24 months, with emphasis on those with complicating comorbidities or postoperative complications. Research questions include predictors of early and late readmission, durable functional outcomes, need for home health or durable medical equipment, and costs of ongoing care in medically complex patients. Findings inform care-transition programs, post-acute care placement strategies, and payer investments in outpatient support to reduce avoidable utilization and improve long-term outcomes for this high-cost DRG.

    Related Codes

    650-KIDNEY-TRANSPLANT-WITH-HEMODIALYSIS-WITH-MCC

    Kidney Transplant with Hemodialysis with Major Complication or Comorbidity: Inpatient Reimbursement Overview

    651-KIDNEY-TRANSPLANT-WITH-HEMODIALYSIS-WITHOUT-MCC

    Kidney Transplant with Hemodialysis without MCC: Inpatient Reimbursement Overview

    652-KIDNEY-TRANSPLANT

    Kidney Transplant: Inpatient Reimbursement Overview

    653-MAJOR-BLADDER-PROCEDURES-WITH-MCC

    Major Bladder Procedures with MCC: Inpatient Reimbursement Overview

    655-MAJOR-BLADDER-PROCEDURES-WITHOUT-CC-MCC

    Major Bladder Procedures without CC/MCC: Inpatient Reimbursement Overview

    656-KIDNEY-AND-URETER-PROCEDURES-FOR-NEOPLASM-WITH-MCC

    Kidney and Ureter Procedures for Neoplasm with MCC: Inpatient Reimbursement Overview

    657-KIDNEY-AND-URETER-PROCEDURES-FOR-NEOPLASM-WITH-CC

    Kidney and Ureter Procedures for Neoplasm with CC: Inpatient Reimbursement Overview

    658-KIDNEY-AND-URETER-PROCEDURES-FOR-NEOPLASM-WITHOUT-CC-MCC

    Kidney and Ureter Procedures for Neoplasm without CC/MCC: Inpatient Reimbursement Overview

    659-KIDNEY-AND-URETER-PROCEDURES-FOR-NON-NEOPLASM-WITH-MCC

    Kidney and Ureter Procedures for Non-Neoplasm with MCC: Inpatient Reimbursement Overview

    660-KIDNEY-AND-URETER-PROCEDURES-FOR-NON-NEOPLASM-WITH-CC

    Kidney and Ureter Procedures for Non-Neoplasm with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 41

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.